Present | Associate Professor of Pharmacy Practice, Campbell University | |
|
Disciplines
Research Interests
Grants
2017 - Present | An interprofessional transformative learning experience 2017 - present for health professions students with direct application to care for patients with substance use disorders |
Duke University School of Medicine Division of Addiction Medicine | |
Role: Co-Investigator | |
$3,500 | |
2017 - Present | An interprofessional transformative learning experience for health professions students with direct application to care for patients with substance use disorders |
Duke University School of Medicine Duke AHEAD Supporting Health Professions Educators (DASHE) | |
Role: Co-Investigator | |
$2,500 | |
2017 - Present | An interprofessional transformative learning experience for health professions students with direct application to care for patients with substance use disorders |
Duke University Josiah Charles Trent Memorial Foundation | |
Role: Co-Investigator | |
$2,500 | |
2015 - Present | Stemming the opiate epidemic through education and outreach |
Duke University Duke Institute for Brain Sciences | |
Role: Co-Investigator | |
$50,000 |
Professional Service and Affiliations
2017 - Present | Co-Chair, CPHSC Curriculum Committee | 2016 - Present | Member, College of Psychiatric and Neurologic Pharmacists Teaching Committee | 2015 - Present | Member, CPHS Ad-Hoc Naplex Review Committee | 2015 - Present | Member, CPHS Curriculum Endocrine Subcommittee | 2015 - Present | Leader and Member, CPHS Curriculum: Neurology-Psychiatry Subcommittee | 2013 - Present | Member, American Association of Colleges of Pharmacy | 2013 - Present | Member, American Pharmacists Association | 2013 - Present | Member, CPHS Continuing Education Committee | 2013 - Present | Member, CPHS Peer-Review Committee | 2013 - Present | Member, Duke AHEC/SR-AHEC Pharmacy Continuing Education Programming Committee | 2008 - Present | Member, CUSOP IM/ID/Academia Residency Committee | 2004 - Present | Member, College of Psychiatric and Neurologic Pharmacists | 2012 - 2015 | Member, Association of Academic Psychiatry | 2009 - 2013 | Member, Association of Medicine and Psychiatry | 2009 - 2013 | Member, North Carolina Association of Pharmacists | 2011 - 2012 | Board Member & Advisory Board Member, North Carolina Pharmacist Recovery Network | 2010 - 2012 | Associate Member and Chair of Clinical Pharmacy Committee, Association of Medicine – Psychiatry | 2010 - 2012 | Member, College of Psychiatric and Neurologic Pharmacists Medicine-Psychiatry Discussion Group | 2009 - 2010 | Member, College of Psychiatric and Neurologic Pharmacists Programming Committee | 2008 - 2008 | Member, College of Psychiatric and Neurologic Pharmacists Membership Committee |
Honors and Awards
- Interprofessional Educator of the Year Award, conferred by Duke AHEAD, 2016
- Duke Pharmacy Service Award, conferred by Duke Hospital Department of Pharmacy, 2012
- Distinguished Young Pharmacist Award, conferred by North Carolina Association of Pharmacists, 2012
- Association of Academic Psychiatry Educator Award, conferred by Association of Academic Psychiatry, 2012
- AMERSA Conference Travel Award, 2017
Courses
- PHAR 585, Drug Induced Disorders, Neurology
- PHAR 521, Treatment of Substance Abuse Disorders
- PH 305, Pharmacy in the US Healthcare Systems
- PHAR 521, Current Evidence-Based Treatment for Mental Health Disorders
- CLNR 541, Behavioral Medicine
- PHAR 545, Treatment of Schizophrenia
- PHAR 545, Treatment of Men’s Health Disorders
- PHAR 545, Treatment of Bipolar Disorder
- PHAR 545, Treatment of Anxiety Spectrum Disorders
- PHAR 585, Drug Induced Disorders, Psychiatry
- PHAR 699, Professional Presentation Seminar
- PHAR 544, Introduction to Clinical Research Design and Medical Literature Evaluation
- PHAR 501, Disorders of Sodium-Fluid Balance
- MPAP 516, Psychotic Disorders
- MPAP 517, Men's Health
- MPAP 516, Bipolar Disorder
- PHAR 545, Treatment of Sleep Disorders
- DPT 710, Treatment of Psychiatric Disorders
- PHAR 509, Therapeutic Drug Monitoring of Psychotropic Medications
- MPAP 516, Attention Deficit Hyperactivity Disorder
- PHAR 545, Treatment of Toxidromes
- PHAR 545, Treatment of Opioid and Alcohol Use Disorders
- DPT 710, Treatment of Neurological Disorders
- OMED 583, Schizophrenia
- OMED 583, Cognitive Disorders
- MPAP 516, Alcohol Use Disorders
2015 - Present | M. Med., University of Michigan ‐ Health Professions Education | |
|
||
2006 - 2007 | UNC Hospitals ‐ Psychiatry Specialty Residency | |
|
||
2005 - 2006 | DCH Regional Medical Center ‐ Pharmacy Practice Residency | |
|
||
2000 - 2004 | Pharm.D., Mercer University | |
|